PharmaBoardroom

Interview: Antonio Carlos Matos Da Silva – General Manager,…

Antonio Carlos Matos da Silva, general manager of Roche Ecuador explains how his ability to manage by influence has helped him transition smoothly…

Interview: Ross Glover – General Manager, Taiho Pharma…

Taiho Pharmaceutical Co., Ltd. (TPC), Japan, part of Otsuka Holdings, established its Canadian affiliate in 2017. Ross Glover, general manager for…

Top 20 Pharma Companies in Brazil Ranking 2017

The Top 20 pharma companies in Brazil for 2017, combining the data for both the retail and non-retail markets. Sanofi leads the way, followed by local…

Brazil Facts & Figures Snapshot

The Latin American pharmaceutical market in comparison. Brazil is by far the largest market. GDP real growth in Latin America regional…

Interview: Andrzej Tarnkowski – Founder and Owner, Antar,…

Andrzej Tarnkowski, founder and owner of Antar, a Polish success story within the orthopaedic field, discusses the company’s successful…

Marina Vasiliou – Managing Director, Biogen Canada

At the company’s 40th anniversary, Biogen’s Canadian head Marina Vasiliou gives an insight into her priorities as new managing director, her…

Indian Biosimilars: Going Global

Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven by some key global biologic drugs…

Aki Kasvi – General Manager; Mindaugas Plieskis – Head of…

Aki Kasvi and Mindaugas Plieskis of Janssen Baltics discuss their strategic priorities, acting as a strategic partner within the region, and ensuring…

Interview: Greg Engel – CEO, Organigram, Canada

Looking back on his first year as CEO of Organigram, Greg Engel proudly highlights the successful transition of the company from being a low-cost to a…